JAK2 and non-small cell lung carcinoma: For example, the membrane bile acid receptor TGR5 has been shown to drive NSCLC progression by activating the JAK2/STAT3 signaling pathway, thereby promoting cell proliferation and migration; its overexpression is also associated with a poor prognosis in patients with NSCLC [14].